Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
0.2370
+0.0024 (1.02%)
Feb 2, 2026, 4:00 PM EST - Market closed
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $10.73 million as of February 2, 2026. Its market cap has decreased by -67.58% in one year.
Market Cap
10.73M
Enterprise Value
10.46M
1-Year Change
-67.58%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $10.73M, a decrease of -96.32%. That is a compound annual growth rate of -27.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 10.62M | -19.74% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curis | 11.61M |
| Bolt Biotherapeutics | 11.32M |
| Imunon | 11.29M |
| Phio Pharmaceuticals | 10.87M |
| GridAI Technologies | 10.52M |
| NuCana | 10.45M |
| BioRestorative Therapies | 10.12M |
| Edesa Biotech | 9.75M |